Dupont Capital Management’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.5K Hold
100,000
0.21% 13
2026
Q1
$6.64K Hold
100,000
﹤0.01% 73
2025
Q4
$4.33K Hold
100,000
﹤0.01% 73
2025
Q3
$3.76K Hold
100,000
﹤0.01% 77
2025
Q2
$4.85K Hold
100,000
﹤0.01% 74
2025
Q1
$3.3K Hold
100,000
﹤0.01% 74
2024
Q4
$4.87K Hold
100,000
﹤0.01% 76
2024
Q3
$7.95K Hold
100,000
﹤0.01% 70
2024
Q2
$5.9K Hold
100,000
﹤0.01% 74
2024
Q1
$10.5K Hold
100,000
﹤0.01% 73
2023
Q4
$2K Hold
100,000
﹤0.01% 90
2023
Q3
$8.5K Hold
100,000
﹤0.01% 106
2023
Q2
$4.58K Hold
100,000
﹤0.01% 504
2023
Q1
$3.52K Hold
100,000
﹤0.01% 622
2022
Q4
$3.8K Hold
100,000
﹤0.01% 1199
2022
Q3
$4K Hold
100,000
﹤0.01% 1337
2022
Q2
$12K Hold
100,000
﹤0.01% 1364
2022
Q1
$24K Hold
100,000
﹤0.01% 1406
2021
Q4
$77K Hold
100,000
﹤0.01% 1327
2021
Q3
$63K Hold
100,000
﹤0.01% 1386
2021
Q2
$107K Buy
+100,000
New +$71.3K ﹤0.01% 1372

Other funds holding COCHW

Dupont Capital Management's COCHW Position: Q2 2026 in Review

Dupont Capital Management held its Envoy Medical Warrant (COCHW) position steady in Q2 2026 at 100,000 shares worth $4.5K. The position accounts for 0.21% of the portfolio, ranked #13.

Dupont Capital Management first reported a position in COCHW in Q2 2021 and has held it in 21 quarters since. The position peaked at $107K in Q2 2021. 4 funds tracked by Wall St. Rank hold COCHW as of Q2 2026.

  • Dupont Capital Management held 100,000 shares of Envoy Medical Warrant worth $4.5K as of Q2 2026.
  • Dupont Capital Management left its Envoy Medical Warrant share count unchanged in Q2 2026.
  • Envoy Medical Warrant made up 0.21% of Dupont Capital Management's portfolio in Q2 2026, its #13 holding.
  • Dupont Capital Management first reported a position in Envoy Medical Warrant in Q2 2021 and has held it in 21 quarters since.
  • Dupont Capital Management's Envoy Medical Warrant position peaked at $107K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q2 2026.

Based on Dupont Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.